secwatch / observer
8-K filed April 23, 2026, 7:59 PM ET ticker SMNR CIK 0001913577
other material confidence high sentiment negative materiality 0.75

Semnur terminates two material financing agreements totaling $120M in potential proceeds

Semnur Pharmaceuticals, Inc.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Semnur Pharmaceuticals, Inc. terminated Securities Purchase Agreement with Biconomy PTE. Ltd (effective 2026-04-20).

Action
termination
Agreement
equity purchase
Counterparty
Biconomy PTE. Ltd
Effective
2026-04-20
Exact text from the filing
the Company delivered a notice of termination to Biconomy pursuant to Section 8 of the Semnur/Biconomy SPA upon which the Semnur/Biconomy SPA was terminated, effective as of April 20, 2026
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Semnur Pharmaceuticals, Inc. terminated Securities Purchase Agreement with JW Capital Securities Limited (effective 2026-04-20).

Action
termination
Agreement
equity purchase
Counterparty
JW Capital Securities Limited
Effective
2026-04-20
Exact text from the filing
the Company and the Subsidiary delivered a notice of termination to JW Capital Securities Limited pursuant to Section 8 of the PIPE SPA, upon which the PIPE SPA was terminated, effective as of April 20, 2026
View on SEC.gov

Browse all material agreements →

Semnur Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-26-173690
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.